Billable / Specific Code
ICD-10-CM C49.8 is the diagnosis code for Malignant neoplasm of overlapping sites of connective and soft tissue. This code falls under the section "Malignant neoplasms of mesothelial and soft tissue" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where C49.8 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C49.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C49.8 is the ICD-10-CM diagnosis code for "Malignant neoplasm of overlapping sites of connective and soft tissue". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C49.8 is C49 ("Malignant neoplasm of other connective and soft tissue"). C49.8 provides a more specific classification within this category.
C49.8 is located in Section C45-C49 — "Malignant neoplasms of mesothelial and soft tissue" within Chapter 2 of the ICD-10-CM Tabular List.
Use C49.8 when the patients documented diagnosis matches "Malignant neoplasm of overlapping sites of connective and soft tissue" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of overlapping sites of connective and soft tissue is C49.8.
Yes, C49.8 can be used as a primary diagnosis code since it is billable and specific.
C49.8 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C49.8 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.